Precision ADC Platform for Safer Glucocorticoid Therapies
This invention introduces a precision antibody-drug conjugate (ADC) platform that couples glucocorticoids to antibodies for targeted drug delivery. By ensuring controlled, intracellular release within diseased cells, the system significantly reduces systemic side effects and expands the therapeutic window for glucocorticoid treatments across oncology,...
Published: 10/17/2025
|
Inventor(s): Lawrence Tumey, Aiman Yaseen
Keywords(s): Technologies
Category(s): Campus > Binghamton University
|